• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of biochemjBJ Latest papers and much more!
Biochem J. Oct 1, 1990; 271(1): 75–86.
PMCID: PMC1149515

Human liver iduronate-2-sulphatase. Purification, characterization and catalytic properties.

Abstract

Human iduronate-2-sulphatase (EC 3.1.6.13), which is involved in the lysosomal degradation of the glycosaminoglycans heparan sulphate and dermatan sulphate, was purified more than 500,000-fold in 5% yield from liver with a six-step column procedure, which consisted of a concanavalin A-Sepharose-Blue A-agarose coupled step, chromatofocusing, gel filtration on TSK HW 50S-Fractogel, hydrophobic separation on phenyl-Sepharose CL-4B and size separation on TSK G3000SW Ultrapac. Two major forms were identified. Form A and form B, with pI values of 4.5 and less than 4.0 respectively, separated at the chromatofocusing step in approximately equal amounts of recovered enzyme activity. By gel-filtration methods form A had a native molecular mass in the range 42-65 kDa. When analysed by SDS/PAGE, dithioerythritol-reduced and non-reduced form A and form B consistently contained polypeptides of molecular masses 42 kDa and 14 kDa. Iduronate-2-sulphatase was purified from human kidney, placenta and lung, and form A was shown to have similar native molecular mass and subunit components to those observed for liver enzyme. Both forms of liver iduronate-2-sulphatase were active towards a variety of substrates derived from heparin and dermatan sulphate. Kinetic parameters (Km and Kcat) of form A were determined with a variety of substrates matching structural aspects of the physiological substrates in vivo, namely heparan sulphate, heparin and dermatan sulphate. Substrate with 6-sulphate esters on the aglycone residue adjacent to the iduronic acid 2-sulphate residue being attack were hydrolysed with catalytic efficiencies up to 200 times above that observed for the simplest disaccharide substrate without a 6-sulphated aglycone residue. The effect of incubation pH on enzyme activity towards the variety of substrates evaluated was complex and dependent on substrate aglycone structure, substrate concentration, buffer type and the presence of other proteins. Sulphate and phosphate ions and a number of substrate and product analogues were potent inhibitor of form A and form B enzyme activities.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Archer IM, Harper PS, Wusteman FS. Multiple forms of iduronate 2-sulphate sulphatase in human tissues and body fluids. Biochim Biophys Acta. 1982 Nov 9;708(2):134–140. [PubMed]
  • Cantz M, Chrambach A, Bach G, Neufeld EF. The Hunter corrective factor. Purification and preliminary characterization. J Biol Chem. 1972 Sep 10;247(17):5456–5462. [PubMed]
  • Clements PR, Mahuran DJ, Hopwood JJ. Improved concanavalin A-Sepharose elution by specific readsorption of glycoproteins. J Chromatogr. 1983 May 20;261(1):77–82. [PubMed]
  • Clements PR, Brooks DA, Saccone GT, Hopwood JJ. Human alpha-L-iduronidase. 1. Purification, monoclonal antibody production, native and subunit molecular mass. Eur J Biochem. 1985 Oct 1;152(1):21–28. [PubMed]
  • Clements PR, Muller V, Hopwood JJ. Human alpha-L-iduronidase. 2. Catalytic properties. Eur J Biochem. 1985 Oct 1;152(1):29–34. [PubMed]
  • Clements PR, Brooks DA, McCourt PA, Hopwood JJ. Immunopurification and characterization of human alpha-L-iduronidase with the use of monoclonal antibodies. Biochem J. 1989 Apr 1;259(1):199–208. [PMC free article] [PubMed]
  • Daniele A, Di Natale P. Hunter syndrome: presence of material cross-reacting with antibodies against iduronate sulfatase. Hum Genet. 1987 Mar;75(3):234–238. [PubMed]
  • Di Natale P, Daniele A. Iduronate sulfatase from human placenta. Biochim Biophys Acta. 1985 May 8;839(3):258–261. [PubMed]
  • Di Natale P, Ronsisvalle L. Identification and partial characterization of two enzyme forms of iduronate sulfatase from human placenta. Biochim Biophys Acta. 1981 Sep 15;661(1):106–111. [PubMed]
  • Freeman C, Hopwood JJ. Human liver sulphamate sulphohydrolase. Determinations of native protein and subunit Mr values and influence of substrate agylcone structure on catalytic properties. Biochem J. 1986 Feb 15;234(1):83–92. [PMC free article] [PubMed]
  • Freeman C, Hopwood JJ. Human liver N-acetylglucosamine-6-sulphate sulphatase. Catalytic properties. Biochem J. 1987 Sep 1;246(2):355–365. [PMC free article] [PubMed]
  • Freeman C, Hopwood JJ. Human liver glucuronate 2-sulphatase. Purification, characterization and catalytic properties. Biochem J. 1989 Apr 1;259(1):209–216. [PMC free article] [PubMed]
  • Freeman C, Clements PR, Hopwood JJ. Human liver N-acetylglucosamine-6-sulphate sulphatase. Purification and characterization. Biochem J. 1987 Sep 1;246(2):347–354. [PMC free article] [PubMed]
  • Gibson GJ, Saccone GT, Brooks DA, Clements PR, Hopwood JJ. Human N-acetylgalactosamine-4-sulphate sulphatase. Purification, monoclonal antibody production and native and subunit Mr values. Biochem J. 1987 Dec 15;248(3):755–764. [PMC free article] [PubMed]
  • Hopwood JJ. alpha-L-iduronidase, beta-D-glucuronidase, and 2-sulfo-L-iduronate 2-sulfatase: preparation and characterization of radioactive substrates from heparin. Carbohydr Res. 1979 Mar;69:203–216. [PubMed]
  • Hopwood JJ, Elliott H. Selective depolymerisation of heparin to produce radio-labelled substrates for sulfamidase, 2-acetamido-2-deoxy-alpha-D-glucosidase, acetyl-CoA:2-amino-2-deoxy-alpha-D-glucoside N-acetyltransferase, and 2-acetamido-2-deoxy-D-glucose 6-sulfate sulfatase. Carbohydr Res. 1981 May 1;91(2):165–190. [PubMed]
  • Hopwood JJ, Elliott H. Diagnosis of Sanfilippo type A syndrome by estimation of sulfamidase activity using a radiolabelled tetrasaccharide substrate. Clin Chim Acta. 1982 Aug 18;123(3):241–250. [PubMed]
  • Hopwood JJ, Muller VJ. Selective depolymerisation of dermatan sulfate: production of radiolabelled substrates for alpha-L-iduronidase, sulfoiduronate sulfatase, and beta-D-glucuronidase. Carbohydr Res. 1983 Oct 28;122(2):227–239. [PubMed]
  • Hopwood JJ, Elliott H, Muller VJ, Saccone GT. Diagnosis of Maroteaux-Lamy syndrome by the use of radiolabelled oligosaccharides as substrates for the determination of arylsulphatase B activity. Biochem J. 1986 Mar 15;234(3):507–514. [PMC free article] [PubMed]
  • Karamanos NK, Hjerpe A, Tsegenidis T, Engfeldt B, Antonopoulos CA. Determination of iduronic acid and glucuronic acid in glycosaminoglycans after stoichiometric reduction and depolymerization using high-performance liquid chromatography and ultraviolet detection. Anal Biochem. 1988 Aug 1;172(2):410–419. [PubMed]
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. [PubMed]
  • Lissens W, Zenati A, Liebaers I. Polyclonal antibodies against iduronate 2-sulphate sulphatase from human urine. Biochim Biophys Acta. 1984 Oct 16;801(3):365–371. [PubMed]
  • Mahuran D, Clements P, Carrella M, Strasberg PM. A high recovery method for concentrating microgram quantities of protein from large volumes of solution. Anal Biochem. 1983 Mar;129(2):513–516. [PubMed]
  • Mahuran D, Clements P, Hopwood J. A rapid four column purification of 2-deoxy-D-glucoside-2-sulphamate sulphohydrolase from human liver. Biochim Biophys Acta. 1983 Jun 9;757(3):359–365. [PubMed]
  • Merle P, Kadenbach B. The subunit composition of mammalian cytochrome c oxidase. Eur J Biochem. 1980 Apr;105(3):499–507. [PubMed]
  • Merril CR, Goldman D, Sedman SA, Ebert MH. Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins. Science. 1981 Mar 27;211(4489):1437–1438. [PubMed]
  • Shaklee PN, Glaser JH, Conrad HE. A sulfatase specific for glucuronic acid 2-sulfate residues in glycosaminoglycans. J Biol Chem. 1985 Aug 5;260(16):9146–9149. [PubMed]
  • Tasheva B, Dessev G. Artifacts in sodium dodecyl sulfate-polyacrylamide gel electrophoresis due to 2-mercaptoethanol. Anal Biochem. 1983 Feb 15;129(1):98–102. [PubMed]
  • Wasteson A, Neufeld EF. Iduronate sulfatase from human plasma. Methods Enzymol. 1982;83:573–578. [PubMed]
  • Yutaka T, Fluharty AL, Stevens RL, Kihara H. Purification and some properties of human liver iduronate sulfatase. J Biochem. 1982 Feb;91(2):433–441. [PubMed]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...